Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00413
|
|||||
Drug Name |
Atazanavir
|
|||||
Synonyms |
(2S)-N-(3-{[(2S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoylamino][(4-(2-pyridyl)phenyl)methyl]amino}(1S,2S)-2-hydroxy-1-benzylpropyl)-2-(methoxycarbonylamino)-3,3-dimethylbutanamide; (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER; ATV; ATZ; Atazanavir (INN); Atazanavir [INN:BAN];BMS-232632; Atazanavirum; BMS 232632; CGP 73547; CGP-73547; DR7; Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate; Latazanavir; METHYL [(1S,4S,5S,10S)-4-BENZYL-1,10-DI-TERT-BUTYL-5-HYDROXY-2,9,12-TRIOXO-7-(4-PYRIDIN-2-YLBENZYL)-13-OXA-3,7,8,11-TETRAAZATETRADEC-1-YL]CARBAMATE; Methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate; Reyataz; Reyataz (TN); Reyataz(TM) (*1:1 sulfate*); Reyataz, BMS-232632, Atazanavir; Zrivada
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Anti-HIV Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C38H52N6O7
|
|||||
Canonical SMILES |
CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC
|
|||||
InChI |
InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1
|
|||||
InChIKey |
AXRYRYVKAWYZBR-GASGPIRDSA-N
|
|||||
CAS Number |
CAS 198904-31-3
|
|||||
Pharmaceutical Properties | Molecular Weight | 704.9 | Topological Polar Surface Area | 171 | ||
Heavy Atom Count | 51 | Rotatable Bond Count | 18 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 9 | |||
XLogP |
5.6
|
|||||
PubChem CID | ||||||
PubChem SID |
10249838
, 103338831
, 104418454
, 124757264
, 124894049
, 125164068
, 125267482
, 126649083
, 126665840
, 126731250
, 127338999
, 127339000
, 127474087
, 134337995
, 134339780
, 135105507
, 135692446
, 137004575
, 142410398
, 143496681
, 144206632
, 14715932
, 14766361
, 14790731
, 15047322
, 152234924
, 152344127
, 160647610
, 17436380
, 24276961
, 46225140
, 46393831
, 46508504
, 46512956
, 49831615
, 50067727
, 50070909
, 50780515
, 51091799
, 53801241
, 57346722
, 621982
, 85177037
, 85177040
, 85177051
, 85177056
, 87225781
, 92308998
, 92729699
, 99437162
|
|||||
ChEBI ID |
ChEBI:37924
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.